North America Medical Device Testing Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Medical Device Testing Market Analysis

  • Healthcare
  • Published Report
  • Jun 2023
  • North America
  • 350 Pages
  • No of Tables: 35
  • No of Figures: 43

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA MEDICAL DEVICE TESTING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 SERVICE TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET TESTING TYPE COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING NEED FOR VERIFICATION VALIDATION OF MEDICAL DEVICES

6.1.2 INCREASING DEMAND FOR IN-VITRO TESTS

6.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES

6.2 RESTRAINTS

6.2.1 BARRIERS TO THE LOCAL DEVELOPMENT OF MEDICAL DEVICES

6.2.2 HIGH COST OF MEDICAL DEVICES

6.3 OPPORTUNITIES

6.3.1 RISE IN HEALTHCARE EXPENDITURE

6.3.2 DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES

6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS

6.4 CHALLENGES

6.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY

6.4.2 LONG LEAD TIME FOR OVERSEAS QUALIFICATION

7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE

7.1 OVERVIEW

7.2 TESTING SERVICES

7.3 INSPECTION SERVICES

7.4 CERTIFICATION SERVICES

8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE

8.1 OVERVIEW

8.2 CHEMICAL/BIOLOGICAL TESTING

8.3 MICROBIOLOGY AND STERILITY TESTING

8.3.1 STERILITY TEST & VALIDATION

8.3.2 BIO BURDEN DETERMINATION

8.3.3 ANTIMICROBIAL ACTIVITY TESTING

8.3.4 PYROGEN & ENDOTOXIN TESTING

8.3.5 OTHERS

8.4 PHYSICAL TESTING

8.4.1 ELECTRICAL SAFETY TESTING

8.4.2 FUNCTIONAL SAFETY TESTING

8.4.3 EMC TESTING

8.4.4 ENVIRONMENTAL TESTING

8.4.5 OTHERS

8.5 CYBERSECURITY TESTING

8.6 OTHERS

9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE

9.1 OVERVIEW

9.2 PRECLINICAL

9.3 CLINICAL

10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE

10.1 OVERVIEW

10.2 OUTSOURCED

10.3 IN-HOUSE

11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS

11.1 OVERVIEW

11.2 CLASS I

11.3 CLASS III

11.4 CLASS II

12 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT

12.1 OVERVIEW

12.2 NON-ACTIVE MEDICAL DEVICE

12.3 ORTHOPEDIC AND DENTAL MEDICAL DEVICE

12.4 ACTIVE IMPLANT MEDICAL DEVICE

12.5 VASCULAR MEDICAL DEVICE

12.6 ACTIVE MEDICAL DEVICE

12.7 IN-VITRO DIAGNOSTICS MEDICAL DEVICE

12.8 OPTHALMIC MEDICAL DEVICE

12.9 OTHERS

13 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY GEOGRAPHY

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 SWOT ANALYSIS

16 COMPANY PROFILE

16.1 LABORATORY CORPORATION OF AMERICA HOLDINGS

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 CHARLES RIVER LABORATORIES.

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENTS

16.3 TUV SUD

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENTS

16.4 WUXI APPTEC

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENTS

16.5 SGS SA

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENTS

16.6 NORTH AMERICAN SCIENCE ASSOCIATES, LLC

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENTS

16.7 HOHENSTEIN

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 BIOMEDICAL DEVICE LABS

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENTS

16.9 BUREAU VERITAS

16.9.1 COMPANY SNAPSHOT

16.9.2 REVENUE ANALYSIS

16.9.3 PRODUCT PORTFOLIO

16.9.4 RECENT DEVELOPMENTS

16.1 CIGNITI

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENTS

16.11 ELEMENT MATERIALS TECHNOLOGY

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENTS

16.12 EUROFINS SCIENTIFIC

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENTS

16.13 GATEWAY ANALYTICAL.

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENTS

16.14 IMR TEST LABS

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENTS

16.15 INTERTEK GROUP PLC

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENTS

16.16 NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENTS

16.17 NSF.

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENTS

16.18 PACE

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENTS

16.19 Q LABORATORIES

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENTS

16.2 TUV RHEINLAND

16.20.1 COMPANY SNAPSHOT

16.20.2 REVENUE ANALYSIS

16.20.3 PRODUCT PORTFOLIO

16.20.4 RECENT DEVELOPMENTS

16.21 UL LLC

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENTS

17 QUESTIONNAIRE

18 RELATED REPORTS

List of Table

TABLE 1 FDA REGULATIONS BASED ON DEVICES TYPE

TABLE 2 PRICES OF ESSENTIAL MEDICAL DEVICES

TABLE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA MEDICAL DEVICE TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 12 U.S. MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 13 U.S. MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 14 U.S. MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 15 U.S. PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 16 U.S. MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 17 U.S. MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 18 U.S. MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 19 U.S. MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 20 CANADA MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 21 CANADA MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 22 CANADA MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 23 CANADA PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 24 CANADA MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 25 CANADA MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 26 CANADA MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 27 CANADA MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 28 MEXICO MEDICAL DEVICE TESTING MARKET, BY SERVICE TYPE, 2021-2030 (USD MILLION)

TABLE 29 MEXICO MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 30 MEXICO MICROBIOLOGY AND STERILITY TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 31 MEXICO PHYSICAL TESTING IN MEDICAL DEVICE TESTING MARKET, BY TESTING TYPE, 2021-2030 (USD MILLION)

TABLE 32 MEXICO MEDICAL DEVICE TESTING MARKET, BY PHASE, 2021-2030 (USD MILLION)

TABLE 33 MEXICO MEDICAL DEVICE TESTING MARKET, BY SOURCING TYPE, 2021-2030 (USD MILLION)

TABLE 34 MEXICO MEDICAL DEVICE TESTING MARKET, BY DEVICE CLASS, 2021-2030 (USD MILLION)

TABLE 35 MEXICO MEDICAL DEVICE TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID

FIGURE 9 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SEGMENTATION

FIGURE 11 INCREASING DEMAND FOR IN-VITRO TESTS AND DEVELOPMENT IN AI AND IOT IN VARIOUS MEDICAL DEVICES ARE EXPECTED TO DRIVE THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICAL DEVICE TESTING MARKET IN 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MEDICAL DEVICE TESTING MARKET

FIGURE 14 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2022

FIGURE 15 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, 2023-2030 (USD MILLION)

FIGURE 16 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, CAGR (2023-2030)

FIGURE 17 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2022

FIGURE 19 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, 2023-2030 (USD MILLION)

FIGURE 20 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, CAGR (2023-2030)

FIGURE 21 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY TESTING TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2022

FIGURE 23 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, 2023-2030 (USD MILLION)

FIGURE 24 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, CAGR (2023-2030)

FIGURE 25 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PHASE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2022

FIGURE 27 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, 2023-2030 (USD MILLION)

FIGURE 28 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, CAGR (2023-2030)

FIGURE 29 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SOURCING TYPE, LIFELINE CURVE

FIGURE 30 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2022

FIGURE 31 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, 2023-2030 (USD MILLION)

FIGURE 32 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, CAGR (2023-2030)

FIGURE 33 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY DEVICE CLASS, LIFELINE CURVE

FIGURE 34 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2022

FIGURE 35 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 36 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 37 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 38 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: SNAPSHOT (2022)

FIGURE 39 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2022)

FIGURE 40 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2023 & 2030)

FIGURE 41 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY COUNTRY (2023 & 2030)

FIGURE 42 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: BY SERVICE TYPE (2023-2030)

FIGURE 43 NORTH AMERICA MEDICAL DEVICE TESTING MARKET: COMPANY SHARE 2022 (%)

Frequently Asked Questions

The North America medical device testing market reaches USD 4,904.16 million by 2030, at a CAGR of 12.0%.
The countries covered in this market report are the U.S., Canada, and Mexico.
the major players operating in the North America medical device testing market are Intertek Group plc, SGS SA, Bureau Veritas, TUV SUD, TUV Rheinland, Pace, Charles River Laboratories., Biomedical Device Labs, UL LLC, North American Science Associates, LLC, WuXi AppTec, NSF., Laboratory Corporation of America Holdings, Eurofins Scientific, NELSON LABORATORIES, LLC- A SOTERA HEALTH COMPANY, Gateway Analytical., Element Materials Technology, Hohenstein, Cigniti, Q Laboratories, and IMR Test Labs among others.
North America medical device testing market is segmented into service type, testing type, phase, sourcing type, device class, and product.
The U.S. is expected to dominate the market due to the high prevalence of medical device testing in the region and the rise in healthcare expenditure.